|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Robert Bristow, PhD, MD, FRCPC Robert Bristow is currently a Clinician-Scientist and Associate Professor with appointments within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto. Since 1999, he has been a Scientist at the Ontario Cancer Institute (Applied Molecular Oncology Division) and a Radiation Oncologist at the Princess Margaret Hospital (University Health Network). He obtained his PhD in Medical Biophysics and his MD at the University of Toronto. His primary research interests are in DNA damage responses and repair, prostate cancer carcinogenesis and prostate cancer treatment response. He has leadership roles in prostate cancer research as the Co-Administrator of the Canadian Prostate Cancer BioResearch Network (CPCRI-funded national molecular prostate cancer research network) and the Chair of the Scientific and Medical Advisory Board of the Prostate Cancer Research Foundation of Canada. He is also Head of the PMH Prostate Cancer Research Program and Chairs the Translational Biology Advisory Group for the Canadian Association for Radiation Oncology (CARO). He is the Editor of an international textbook, The Basic Science of Oncology , and of the journal Radiotherapy and Oncology. He has been a member of NCIC and NIH Biomedical Awards Review Panels, the US Army Prostate Program Review Panel and is the Chair of the Scientific and Medical Advisory Board of the Prostate Cancer Research Foundation of Canada. He has won a Canadian Foundation for Innovation (CFI) Award on two occasions and was made a Canadian Cancer Society Research Scientist in 2004. |
 |
Kristy Brock, PhD Kristy Brock is an Assistant Professor in the University of Toronto Department of Radiation Oncology, and a staff physicist in the Radiation Medicine Program at PMH since 2003. She completed her PhD in Nuclear Engineering and Radiological Sciences at the University of Michigan. Her research interests include deformable image registration, multi-modality imaging for radiation therapy, and quantitative assessment of treatment response, and quantification and evaluation of organ motion and deformation. |
 |
K.S. Clifford Chao, M.D. Dr. Chao was born in 1957. Prior to his moving to US in 1989, he was a board certified radiation oncologist in Taiwan and a research scholar at Japan 's Cancer Research Institute in Tokyo. He began his tenure at the Washington University School of Medicine in St. Louis in 1990 and move up to the rank of associate professor. He was then appointed as Medical Director of Image-guided Therapy program at the University of Texas M.D. Anderson Cancer Center in 2002. He has been serving as principal investigator or investigator for more than a dozen research projects over the past seven years, many of them funded by the National Institutes of Health (NIH) and the Department of Defense. These research endeavors have resulted in several patents related to image-guide diagnosis and therapy. Dr. Chao sits on the editorial boards of several journals, including the International Journal of Radiation Oncology Biology and Physics and the American Journal of Clinical Oncology. He also serves on multiple grant reviewing sections for NIH and international funding agencies. He is the senior editor of two textbooks and the author of more than 100 articles and book chapters. His recent interests have been in addressing challenges facing radiation oncology community pertaining to bridging the knowledge gap and improving operational efficiency to cope with the explosion of overwhelming technology and limited time to meet the standard of patient-physician interaction. He devotes his extracurricular efforts mainly with his family and on fencing and golfing. cchao@mdanderson.com |
 |
Gregory Czarnota, PhD, MD, FRCPC Gregory Czarnota is an MD in the Department of Radiation Oncology at the University of Toronto and a scientist at Sunnybrook and Women's College Health Sciences Centre in the Imaging Discipline. He is conducting research focused on using ultrasound imaging and spectroscopy at conventional and high frequencies to detect apoptosis and other forms of cell death in response to chemotherapy and radiation therapy. His basic science research interests include studies in biochemistry, chromatin biology, biophysics, medicine and oncology. Dr. Czarnota is an avid collector of all things STAR WARS. |
 |
Laura Dawson, MD, FRCPC Laura Dawson is an Associate Professor in the University of Toronto Department of Radiation Oncology, and a staff radiation oncologist in the Radiation Medicine Program at PMH since 2003. She received her MD and specialist qualification from the University of Toronto. Her research interests include hepatobiliary malignancies, liver metastases, central nervous system cancers, high precision radiation, intensity modulated radiation, extra-cranial stereotactic radiation, image guided radiation and normal tissue radiation toxicity. |
 |
Robert Dinniwell, MD, FRCPC Dr. Dinniwell is a Radiation Oncologist at the Princess Margaret Hospital and an Assistant Professor in the Department of Radiation Oncology at the University of Toronto . He received his MD degree at Queen's University and completed his postgraduate training at McMaster University and the University of Toronto. Following his specialty certification in radiation oncology, he undertook a two-year research fellowship as a Strategic Training Fellow in the CIHR-Excellence in Radiation Research for the 21st Century Program at the Princess Margaret Hospital. During this time he undertook research utilizing magnetic resonance imaging with ultra-small superparamagnetic iron oxide for pelvic lymph node target definition to improve the treatment of genitourinary and gynecologic malignancies and completed a Magnetic Resonance Imaging Theory Advanced Diploma. This work will comprise his thesis as a Master's Student at the University of Toronto in the Institute of Medical Science and complete his training in the Royal College of Physicians and Surgeons of Canada Clinician Investigator Program. At present, his major research interest is in the area of medical imaging and the use of novel imaging techniques to visualize the lymphatics and lymphatic flow and the application of these techniques to radiotherapy treatment planning and the management of radiation induced late effects. An avid sailor, Dr. Dinniwell hopes to further his grounding in the art of skiff sailing with his Farr 3.7. |
 |
Anthony Fyles, MD, FRCPC Anthony Fyles is a Professor in the Department of Radiation Oncology at the University of Toronto , and Gynecologic Cancer Site Leader at Princess Margaret Hospital/UHN. He completed his MD and postgraduate training in Radiation Oncology at the University of Toronto and Royal Marsden Hospital. Dr. Fyles has research interests in translational and drug development clinical trials in gynecologic cancer, clinical studies of the tumour microenvironment including hypoxia, and clinical trials in breast cancer. A recent interest is in developing and implementing image guided precision radiotherapy in gynecologic tumours. Outside interests include sports (bicycling and skiing), literature, and film. |
 |
Mary Gospodarowicz, MD, FRCPC FRCR (Hon.) Mary Gospodarowicz is the Professor and Chair of the Department of Radiation Oncology at the University of Toronto. At Princess Margaret Hospital–UHN she is currently the Chief of the Radiation Medicine Program and the Acting Medical Director of the Oncology Program. She received her MD degree and postgraduate training from the University of Toronto and has specialty certifications in internal medicine, medical oncology and radiation oncology. Dr. Gospodarowicz's research interests include clinical trials in prostate cancer, bladder cancer, testis tumours and lymphomas. Currently, her major interest is in developing and implementing image guided precision radiotherapy at PMH. With long standing involvement in late effects research, she is very interested in fostering the newly established survivorship clinical programs and research. In addition to clinical research, she has a major interest in cancer staging and prognostic factors. Dr. Gospodarowicz currently chairs the Task Force on Prognostic Factors for the International Union Against Cancer (UICC) TNM Committee. She also serves as a member of the UICC Executive Committee. Recently, together with Alex Jadad, she has initiated an ?e-UICC? program to actively promote new e-initiatives to raise the standard of cancer care worldwide. In addition, she is the North American Editor of journal Clinical Oncology . She is an honorary fellow of the Royal College of Radiologists in the United Kingdom and an honorary member of the European Society of Therapeutic Radiology and Oncology (ESTRO). Outside work she is passionate about travel, and enjoys literature and the arts. Mary.Gospodarowicz@rmp.uhn.on.ca
|
 |
Richard Hill, PhD Richard Hill is currently a full Professor in the Departments of Medical Biophysics and Radiation Oncology at the University of Toronto. He graduated from St. Johns College, Oxford with a BA in Physics in 1964. Subsequently, he completed a PhD degree in Radiation Biology in 1967 at St Bartholomew's Hospital Medical College in the University of London, and did a post-doctoral fellowship (James Picker Foundation fellow) at the Ontario Cancer Institute (OCI) from 1967-1971. He then joined the scientific staff at the Institute of Cancer Research in Sutton, Surrey before returning to join the scientific staff of the OCI in 1973. He has been a member of the senior scientific staff of the OCI since that time. Presently he is also the Secretary-Treasurer of the Radiation Research Society and a member of the Board of American Society for Therapeutic Radiology and Oncology. Since 1973, Dr. Hill's research has been continuously funded by the National Cancer Institute of Canada, through block grants, individual investigator grants, and more recently through Terry Fox program project grants. He has also held grants from the Medical Research Council of Canada, the Canadian Institutes of Health Research, the Ontario Cancer Research Network and the National Institutes of Health, USA , both individually and jointly with other investigators at the OCI. These grants have supported laboratory and translational research studies in tumour and normal tissue radiobiology, hyperthermia, metastasis and aspects of the tumour microenvironment, notably tumour hypoxia. Since 1991, he has acted as the PI on Terry Fox program project grants, that have brought together both clinical and scientific colleagues to study the various topics mentioned above, particularly the role of tumour hypoxia in treatment outcome and tumour progression and metastasis. He is the co-editor (with Drs Ian Tannock, Rob Bristow and Lea Harrington) of The Basic Science of Oncology , a book that is widely used in basic courses for oncology trainees and has recently been published in its fourth edition. Outside the laboratory he spends his time with family, in various outdoor activities, and traveling. hill@uhnres.utoronto.ca |
 |
David Jaffray, PhD, ABMP David Jaffray is an Associate Professor in the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto. In 2002, Dr. Jaffray joined the Princess Margaret Hospital in Toronto, Canada as Head of Radiation Physics and Senior Scientist within the Ontario Cancer Institute. David holds the Fidani Chair in Radiation Physics and is a principal in the Image-guided Therapy Group of the University Health Network. He graduated from the University of Alberta, Edmonton, Alberta , Canada with a BSc in Physics in 1988 and completed his PhD in the Department of Medical Biophysics at the University of Western Ontario , London , Ontario in 1994. The following 8 years were spent as a Clinical Physicist in the Department of Radiation Oncology at William Beaumont Hospital, Royal Oak, Michigan. Dr. Jaffray become a Board Certified Medical Physicist (ABMP - Radiation Oncology) in 1999. Dr. Jaffray holds numerous peer-reviewed and industry sponsored research grants in the field of image-guided radiation therapy. His current research interests focus on the development of novel approaches to directing and applying radiation therapy and advancing the standard of radiation therapy delivery. |
 |
Fei-Fei Liu, MD, FRCPC Fei-Fei Liu is a Professor in the Departments of Radiation Oncology, Medical Biophysics and Otolaryngology at the University of Toronto, and holds the University of Toronto/Princess Margaret Hospital Dr. Marianno Elia Endowed Chair in Head & Neck Cancer Research. She is a Clinician-Scientist Radiation Oncologist at the Princess Margaret Hospital, and a Senior Scientist at the Ontario Cancer Institute. She graduated from University of Toronto Medical School in 1980, and is certified in Radiation Oncology and Internal Medicine. She is the Head of the Division of Applied Molecular Oncology at the Ontario Cancer Institute, leading a group of 16 scientists and clinician-scientists whose laboratory programs are all focused on translational research involving human cancers. Her own research program is focused on developing and investigating novel molecular therapeutic strategies for human malignancies, delivered in conjunction with radiation therapy. Her laboratory is also involved in translational research investigating the molecular profile for several human cancers including breast and head/neck cancers. She is a member of several peer-review granting agencies including CIHR, NCIC, Terry Fox Program Project, CBCF, and the NCI-US Parent Subcommittee D. She is the Director of a CIHR Research Training Initiative, with the objective to train the next generation of trans-disciplinary scientists in Radiation Medicine. Dr. Liu is passionate about her family with 2 teenage boys, and in her spare time, she loves gourmet foods, cooking, traveling, reading, jogging, snorkeling, and doing volunteer work in health care and education. |
 |
Kathy Mah, MSc, FCCPM Ms. Kathy Mah is currently an Assistant Professor in the Department of Radiation Oncology at the University of Toronto and a Fellow in the Canadian College of Physicists in Medicine. She is the Senior Planning Physicist at the Toronto-Sunnybrook Regional Cancer Centre in Toronto, Ontario . Her fields of expertise include PET/CT imaging for radiation simulation and CT-simulation technologies. She is the author of 14 scientific papers and five book chapters. Her major areas of clinical and research interests are the integration and use of technologies to help physicians define clinical target volumes more accurately. The integration of FDG-PET/CT and MRI images into radiation therapy planning and their impact on target localization and associated uncertainties are her current research projects. |
 |
Lee Manchul, MD, MHPE, FRCPC Lee Manchul is an Assistant Professor and Director of Continuing Education for the Department of Radiation Oncology at the University of Toronto. She is a Radiation Oncologist at the Princess Margaret Hospital in Toronto. She obtained her Masters' degree in Health Professions Education from the University of Illinois at Chicago in 2002 (for which she won the 2003 best MHPE thesis award). Her thesis research determined the interprofessional learning needs of the radiation oncology team as well as strategies to overcome barriers to interprofessional education in radiation oncology. Lee has served as Chair of the Education Research Committee for the Society for Academic Continuing Education. She chairs the American Association of Medical College Group on Educational Affairs CME Section and is Chair of the University of Toronto Faculty Council Continuing Education Committee. Her current interests are in creating and evaluating interprofessional education initiatives. lee.manchul@rmp.uhn.on.ca |
 |
Cynthia Ménard, MD, FRCPC Cynthia Ménard is a Clinician Scientist in the Radiation Medicine Program at Princess Margaret Hospital, Toronto , and is the co-director of the Gamma Knife Centre. She received her M.D. degree from the University of Calgary in 1996, and completed her residency in Radiation Oncology at the University of Alberta, Edmonton, in 2001. She was a research fellow in the Radiation Oncology Branch of the National Cancer Institute (NCI) until 2003, where she was subsequently appointed Staff Clinician and Head of the Radiation Oncology Molecular Imaging Section. In this role, she pursued translational research in the development, validation, and clinical application of novel MR imaging techniques to radiotherapy. |
 |
Michael Milosevic, MD, FRCPC Michael Milosevic is an Associate Professor in the University of Toronto Department of Radiation Oncology and Radiation Oncologist at the Princess Margaret Hospital where he is a member of both the Gynecologic and GU site groups. He is also Director of Research in the Radiation Medicine Program at PMH. His research focuses on how tumor hypoxia and other biologic abnormalities influence the behavior of cervix and prostate cancer. He is also interest in high precision radiotherapy, and in the use of novel imaging techniques to guide treatment delivery. |
 |
Peter O'Brien, FCCPM Peter O'Brien is the Chief Physicist and Manager and Head of the Medical Physics department at the Toronto Sunnybrook Regional Cancer Centre (TSRCC), the cancer program of the Sunnybrook and Women's College Health Sciences Centre. He is also an Assistant Professor in the Department of Radiation Oncology, University of Toronto. Mr. O'Brien received undergraduate and graduate training in atomic physics at the University of Guelph and trained in Medical Physics with the Alberta Cancer Board in Calgary, Alberta. He is certified as a Fellow of the Canadian College of Physicists in Medicine. Mr. O'Brien is the Chair of The Canadian Organization of Medical Physicists and is active on many professional committees and boards. He has a particular interest in the implementation and improvement of instrumentation and techniques for precision radiation therapy. He has also worked extensively to develop and promote Canadian National Standards for Quality Assurance in radiation treatment facilities. Mr. O'Brien is the director of the Medical Physics Residency Training program at the TSRCC and is working to integrate the training programs in Toronto leading to accreditation. Away from work Peter enjoys golf, sailing, and his family. |
 |
Jean-Philippe Pignol, MD, PhD, FRCPC Jean-Philippe Pignol is an Associate Professor in the Department of Radiation Oncology at the University of Toronto. At Toronto Sunnybrook Regional Cancer Centre he is currently a Clinician Scientist in Imaging and the Director of Research of the Radiation Oncology Department. He received his MD degree from the University of Strasbourg, France and has specialty certifications in radiation oncology. He also received a PhD degree in Nuclear Physics at the same University. Dr. Pignol's research interests include innovative technology for cancer radiation treatment including Heavy Particles, radiosensitisation using halogenated compounds, IMRT and brachytherapy. His clinical research interest are in breast cancer, with a specific focus on using innovative technology to reduce treatment side effects. Currently, his major interest is in developing and implementing image guided brachytherapy at TSRCC and an innovative radiosurgery prototype based on intermediate energy photon that dramatically reduces the radiological penumbra. Outside work he is passionate about sailing, travel and outdoors activities. He is a passionate piano player. Jean-Philippe.Pignol@sunnybrook.ca |
 |
David Piwnica-Worms, MD, PhD David Piwnica-Worms, (Washington University), is Professor of Radiology, Professor of Molecular Biology and Pharmacology, and Director of the Molecular Imaging Center. His research interests encompass applications of molecular cell biology, biochemistry, and chemistry to molecular imaging in vivo with specific focus on development of reporter systems for imaging gene expression in vivo , imaging signal transduction and protein-protein interactions in whole cells and animal models, and biochemical analysis of the function and regulation of the multidrug resistance P-glycoprotein family of transporters, as well as translational research directed toward imaging in vivo using technetium-99m labeled radiopharmaceuticals in nuclear medicine applications. He is a founding member and 2004 President of the Society for Molecular Imaging. |
 |
Michael Sharpe, PhD Michael Sharpe is an Assistant Professor at the University of Toronto Department of Radiation Oncology, and a staff physicist in the Radiation Medicine Program at PMH since 2002. He received his PhD in Medical Biophysics at the University of Western Ontario. His research interests include external beam treatment planning, image guided treatment, multimodality imaging in treatment planning, breath hold immobilization using Active Breathing Control, and radiation therapy for breast cancer and soft tissue sarcomas. |
 |
Lillian Siu, MD, FRCPC Lillian Siu is a staff physician in the Department of Medical Oncology and Hematology at Princess Margaret Hospital since 1998, and is an associate professor at the University of Toronto. Dr. Siu is Director of the Phase I Program and Co-Director of the Robert and Maggie Bras and Family New Drug Development Program at Princess Margaret Hospital. She graduated from the University of Toronto Faculty of Medicine in 1991. After her residency in Medical Oncology at Princess Margaret Hospital, she completed Drug Development Fellowships at the Princess Margaret Hospital and at the University of Texas Science Center, San Antonio . Dr. Siu's major research focus is in the area of new anticancer drug development, particularly with respect to head and neck and gastrointestinal malignancies. She is the Associate Director of the Drug Development Program at the Princess Margaret Hospital . Dr. Siu is the recipient of numerous awards such as the Elsie Winifred Crann Award at the University of Toronto in 2001, Teaching Awards in the Medical Oncology Residency Program for the last six consecutive years Lillian.siu@uhn.on.ca |
 |
Philip J. Tofilon, Ph.D. Philip Tofilon received his undergraduate degree in physiology from the University of Illinois ( Urbana ) in 1977. He began his graduate training at the University of California San Francisco (UCSF) in the pharmacology department and then moved with his thesis advisor to the University of Nebraska Medical Center in Omaha where he received his Ph.D. in 1981. In the fall of 1981 Phil returned to UCSF accepting a postdoctoral fellowship with Dr. Dennis Deen in the Brain Tumor Research Center. With Dr. Deen as a mentor, he was introduced to radiobiology, which has continued to be his primary area of research. In 1984, Phil joined the faculty of the Department of Experimental Radiation Oncology at the University of Texas M.D. Anderson Cancer Center in Houston as an assistant professor. His research at M.D. Anderson focused on drug-radiation interactions. In addition, Phil's studies were expanded to include investigations into the cellular and molecular mechanisms responsible for the injury that occurs in normal brain tissue after radiotherapy. He was eventually promoted to professor in 1996 with a joint appointment as professor in the Department of Neurosurgery. In June of 2001, Phil relocated from M.D. Anderson to the National Cancer Institute accepting the position as Chief of the newly created Molecular Radiation Therapeutics Branch. His current research is focused on the identification of the molecular determinants of radiosensitivity and the development of molecularly targeted radiosensitizers. |
 |
Yee Ung, MD, FRCPC Yee Ung is an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. At the Toronto Sunnybrook Regional Cancer Centre, he is the head of the Lung Site group. He is also co-Chair of the Cancer Care Ontario Practice Guideline Inititative Group Lung Cancer Disease Site, an executive member of the National Cancer Institute of Canada Clinical Trials Group Lung Disease Site and on the board of directors of Lung Cancer Canada. He is a graduate of the Univeristy of Alberta and has specialty certification in radiation oncology. His research interests include functional imaging, clinical trials and evidence based medicine guidelines. His clinical areas are lung cancer and gastrointestinal cancers. |
 |
Katherine Vallis, MB, BS, PhD, MRCP, FRCR, FRCPC Katherine Vallis is an Associate Professor of Radiation Oncology and Medical Biophysics at the University of Toronto. She is a Staff Radiation Oncologist at the Princess Margaret Hospital where she has an interest in clinical trials concerned with the optimization of radiation therapy for the treatment of breast cancer. She is also a Scientist within the Division of Applied Molecular Oncology at the Ontario Cancer Institute. She is engaged in research aimed at the development of novel radiopharamaceutical agents for the treatment of cancer. katherine.vallis@rmp.uhn.on.ca |
 |
Shun Wong , MD , FRCPC Shun Wong is the Chief of the Department of Radiation Oncology and Head of the Radiation Treatment Program at Toronto Sunnybrook Regional Cancer Centre, Sunnybrook and Women's College Health Sciences Centre. He is also a Professor and Vice Chair of the Department of Radiation Oncology, University of Toronto. Dr. Wong obtained his MD and his Radiation Oncology training at the University of Toronto. He did a research fellowship in Experimental Radiotherapy at the MD Anderson Cancer Centre in Houston, Texas, before returning to Toronto as staff Radiation Oncologist at the Princess Margaret Hospital where he stayed until 2002. Dr. Wong's clinical interest is in gastrointestinal cancer and brain tumour. Internationally recognized for his research in the radiobiology of the central nervous system, his current research activities are focused on the mechanisms of central nervous system radiation injury and experimental neuroprotective strategies. Outside of radiation oncology, Dr. Wong is an avid tennis player and he enjoys gardening. shun.wong@sunnybrook.ca |
 |
Ivan Yeung Ivan Yeung is an Assistant Professor in the Department of Radiation Oncology at the University of Toronto. He is also the Lead Physicist of the Brachytherapy Program at Princess Margaret Hospital- UHN. He received his Ph.D. degree in Medical Biophysics at the University of Western Ontario and completed his residency training in Radiation Therapy Physics at PMH. Dr. Yeung’s research interest includes functional imaging for application in Radiation Therapy, and Image Guided Brachytherapy. He is one of the pioneers in the field of functional CT imaging extracting functional information from conventional CT scanning. The sites he has studied include the brain, prostate and cervix. Currently, his major research interest is methodology development in functional CT and its application as a monitoring tool in cancer therapies. He is a member of the Communication Committee of the Canadian Organization of Medical Physicists and is involved in managing the COMP website. Off work, he enjoys music, traveling and ice fishing. |
 |
Pat Zanzonico, PhD Pat Zanzonico received his PhD from the Cornell University Graduate School of Medical Sciences in 1972. He is currently Associate Attending Physicist and Associate Laboratory Member at Memorial Sloan-Kettering Cancer Center and Manager of the Center's Nuclear Medicine Research and Small-Animal Imaging Laboratories. Dr. Zanzonico is also Associate Professor of Physics in Radiology at Weill-Cornell Medical College. He is a member of the Editorial Board and past Associate Editor of the Journal of Nuclear Medicine, a Member of the National Council on Radiation Protection and Measurement (NCRP), and Secretary of the Nuclear Medicine Section of the New York Academy of Medicine. He is actively involved in biomedical research on radionuclide-based methods for detecting and localizing tumor hypoxia, immune effector-cell trafficking, patient-specific dosimetry for radionuclide therapies, and small-animal imaging. |